As of today (2024-05-17), Krka d.d.'s share price is €126.00.
Krka d.d.'s Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €6.60. Hence, Krka d.d.'s Price-to-Free-Cash-Flow Ratio for today is 19.10.
The historical rank and industry rank for Krka d.d.'s Price-to-Free-Cash-Flow or its related term are showing as below:
XLJU:KRKG'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.4 Med: 12.69 Max: 54.03
Current: 19.1
During the past 13 years, Krka d.d.'s highest Price-to-Free-Cash-Flow Ratio was 54.03. The lowest was 7.40. And the median was 12.69.
XLJU:KRKG's Price-to-Free-Cash-Flow is ranked better than 57.51% of 506
companies
in the Drug Manufacturers industry
Industry Median: 23.41
vs XLJU:KRKG: 19.10
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Krka d.d. was -43.20% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 16.80% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 24.50% per year.
During the past 13 years, Krka d.d.'s highest 3-Year average Free Cash Flow per Share Growth Rate was 38.30% per year. The lowest was -13.60% per year. And the median was 17.35% per year.
Krka d.d. Price-to-Free-Cash-Flow Historical Data
The historical data trend for Krka d.d.'s Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Krka d.d.'s Price-to-Free-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Krka d.d.'s Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krka d.d.'s Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Krka d.d.'s Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Krka d.d.'s Price-to-Free-Cash-Flow falls into.
Krka d.d. Price-to-Free-Cash-Flow Calculation
Krka d.d.'s Price-to-Free-Cash-Flow ratio for today is calculated as
Krka d.d.'s Share Price of today is €126.00. Krka d.d.'s Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.60.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Krka d.d. Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Krka d.d.'s Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XLJU:KRKG has been successfully added to your 